Gasdermin D (GSDMD) as a new target for the treatment of infection

Ankit Pandeya; Lan Li; Zhenyu Li; Yinan Wei

doi:10.1039/c9md00059c

Gasdermin D (GSDMD) as a new target for the treatment of infection

Ankit Pandeya, Lan Li, Zhenyu Li, Yinan Wei

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Abstract

The discovery of a previously unknown protein, gasdermin D (GSDMD), as the key effector that leads to pyroptosis and NETosis has created much excitement. Since its initial report in Oct. 2015, more than 200 papers have been published on studies of the structure and mechanism of GSDMD and its homologues. The clear connection between infection and inflammasome activation made GSDMD a promising target for the development of anti-infection treatment. In this mini review, we discuss first the current understanding of the structure and mechanism of GSDMD, focusing on its potential as a druggable target, and then recent efforts in the development of inhibitors to interfere with the pore-forming function of GSDMD and thus alleviate the detrimental effects due to pyroptotic cell death.

Original language	English
Pages (from-to)	660-667
Number of pages	8
Journal	MedChemComm
Volume	10
Issue number	5
DOIs	https://doi.org/10.1039/c9md00059c
State	Published - 2019

Bibliographical note

Funding Information:
Y. W. is supported by AHA Great Rivers Affiliate Grant-in-Aid 17GRNT33410327, NSF CHE-1709381, and NIH, NIAID, R56AI137020 and R21AI142063. Z. L. is supported by NIH, NHLBI, HL123927.

Publisher Copyright:
© 2018 The Royal Society of Chemistry.

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Pharmacology
Pharmaceutical Science
Drug Discovery
Organic Chemistry

Access to Document

10.1039/c9md00059c

Cite this

@article{b32b494619a143e68425c2815fab626d,

title = "Gasdermin D (GSDMD) as a new target for the treatment of infection",

abstract = "The discovery of a previously unknown protein, gasdermin D (GSDMD), as the key effector that leads to pyroptosis and NETosis has created much excitement. Since its initial report in Oct. 2015, more than 200 papers have been published on studies of the structure and mechanism of GSDMD and its homologues. The clear connection between infection and inflammasome activation made GSDMD a promising target for the development of anti-infection treatment. In this mini review, we discuss first the current understanding of the structure and mechanism of GSDMD, focusing on its potential as a druggable target, and then recent efforts in the development of inhibitors to interfere with the pore-forming function of GSDMD and thus alleviate the detrimental effects due to pyroptotic cell death.",

author = "Ankit Pandeya and Lan Li and Zhenyu Li and Yinan Wei",

note = "Funding Information: Y. W. is supported by AHA Great Rivers Affiliate Grant-in-Aid 17GRNT33410327, NSF CHE-1709381, and NIH, NIAID, R56AI137020 and R21AI142063. Z. L. is supported by NIH, NHLBI, HL123927. Publisher Copyright: {\textcopyright} 2018 The Royal Society of Chemistry.",

year = "2019",

doi = "10.1039/c9md00059c",

language = "English",

volume = "10",

pages = "660--667",

number = "5",

}

TY - JOUR

T1 - Gasdermin D (GSDMD) as a new target for the treatment of infection

AU - Pandeya, Ankit

AU - Li, Lan

AU - Li, Zhenyu

AU - Wei, Yinan

N1 - Funding Information: Y. W. is supported by AHA Great Rivers Affiliate Grant-in-Aid 17GRNT33410327, NSF CHE-1709381, and NIH, NIAID, R56AI137020 and R21AI142063. Z. L. is supported by NIH, NHLBI, HL123927. Publisher Copyright: © 2018 The Royal Society of Chemistry.

PY - 2019

Y1 - 2019

N2 - The discovery of a previously unknown protein, gasdermin D (GSDMD), as the key effector that leads to pyroptosis and NETosis has created much excitement. Since its initial report in Oct. 2015, more than 200 papers have been published on studies of the structure and mechanism of GSDMD and its homologues. The clear connection between infection and inflammasome activation made GSDMD a promising target for the development of anti-infection treatment. In this mini review, we discuss first the current understanding of the structure and mechanism of GSDMD, focusing on its potential as a druggable target, and then recent efforts in the development of inhibitors to interfere with the pore-forming function of GSDMD and thus alleviate the detrimental effects due to pyroptotic cell death.

AB - The discovery of a previously unknown protein, gasdermin D (GSDMD), as the key effector that leads to pyroptosis and NETosis has created much excitement. Since its initial report in Oct. 2015, more than 200 papers have been published on studies of the structure and mechanism of GSDMD and its homologues. The clear connection between infection and inflammasome activation made GSDMD a promising target for the development of anti-infection treatment. In this mini review, we discuss first the current understanding of the structure and mechanism of GSDMD, focusing on its potential as a druggable target, and then recent efforts in the development of inhibitors to interfere with the pore-forming function of GSDMD and thus alleviate the detrimental effects due to pyroptotic cell death.

UR - http://www.scopus.com/inward/record.url?scp=85066091880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066091880&partnerID=8YFLogxK

U2 - 10.1039/c9md00059c

DO - 10.1039/c9md00059c

M3 - Article

AN - SCOPUS:85066091880

VL - 10

SP - 660

EP - 667

IS - 5

ER -

Gasdermin D (GSDMD) as a new target for the treatment of infection

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this